BUSINESS● LOW2h ago · Oct 29, 2026, 6:40 AM
Takeda Pharmaceutical Non-GAAP EPS of ¥308.00, revenue of ¥2407B; upgrades FY 2026 outlook
Seeking Alpha Tech · global
Takeda Pharmaceutical reported its Non-GAAP EPS and revenue figures, and has upgraded its financial outlook for fiscal year 2026. This indicates the company's current financial performance and future projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoETFs with the biggest Alphabet bets feel the heat as stock slidesSeeking Alpha TechBUSINESS39m agoGold in Ghana: After Damang, is Gold Fields at risk of being ousted from the Tarkwa mine?Jeune Afrique